# Pregabalin Stabilize Cardiovascular Response to Intubation

> **NCT03456947** · PHASE4 · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 90 (actual)

## Conditions studied

- Effect of Laryngoscopy and Tracheal Intubation

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT03456947
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03456947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03456947, "Pregabalin Stabilize Cardiovascular Response to Intubation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03456947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*